Press Office

The growing ATMP pipeline has led to an increase in the demand for plasmid DNA, prompting the pharmaceutical stakeholders to either invest in expanding capabilities or outs... read more
The growing financial burden of bacterial infections, coupled with its impact on mortality rate has led to a rise in the demand for effective therapeutic treatment options th... read more
The introduction of medical drones has led to a remarkable transformation in healthcare delivery to hard-to-reach areas by harnessing state-of-the-art drone technology to i... read more
Given the potential of patient engagement solutions to improve patient satisfaction and health outcomes, such solutions have emerged as indispensable tools and generated s... read more
Pharmaceutical polymers have emerged as one of the versatile materials in the healthcare community owing to their various benefits, includin... read more
In order to overcome the challenges associated with manual systems, stakeholders are gradually adopting automated liquid handling systems, such as automated pipettes and micro... read more
The growing demand for buffers and challenges associated with buffer preparation have prompted various pharmaceutical companies to leverage the expertise of players offering novel buffer preparati... read more
In order to improve bioavailability of poorly water-soluble drugs and achieve their targeted delivery, drug developers have inclined towards utilization of nanoparticle formulation technologies an... read more
AI holds immense potential to overcome challenges related to poor patient recruitment, engagement, monitoring, study design and myriad of other complexities associated with clinical trials&... read more
Allogeneic cell therapies have emerged as a promising and rapidly advancing modality owing to their various benefits, including off-the-shelf availability, do... read more
With the rising demand for more efficient and homogenous antibody drug conjugates, drug developers are increasingly collaborating with technology providers, for leveraging their advanced ADC conjugati... read more
Owing to the rising demand for efficacious biotherapeutics and multiple benefits of single-use bioprocessing systems, the biopharmaceutical industry is gradually shifting its focus from con... read more
Over time, there has been a significant advancement in the way healthcare is delivered, with introduction of women’s digital health solutions to enhance the efficiency and qual... read more
Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz ... read more
Given the potential of deep learning-based technologies to expedite the drug discovery process and improve early-stage diagnosis, the deep ... read more
Owing to organ scarcity and lesser number of donors, the demand for tissue engineering and organ reconstruction has increased notably; as a result, the adoption of advanced 4D bioprinting techno... read more
With the incorporation of error-correcting audible feedback sensors, temperature monitoring strips, disposable components and dose monitoring system,... read more
The necessity to achieve operational excellence, visibility, control and synchronization in bioprocessing, has prompted manufacturers to adopt digital technologies for biologics... read more
The phenomenal success of RNA-based products in tackling the global COVID-19 pandemic, as well as their potential to actualize the concept of personalized medicines has resulted i... read more
Owing to the increasing number of approvals of cell therapies, and a sharp rise in associated clinical trials, the demand for advanced cell therapy consumab... read more
Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, th... read more
Driven by the rising demand for biologics and recent advancements in this field, biopharmaceutical filtration systems are being widely adopted by various stakeholders, in order to en... read more
Clinical trials are a fundamental requirement for evaluating the safety and efficacy of novel therapeutics; patient recruitment and retention are two major bottlenecks duri... read more
Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-worl... read more
The bioavailability enhancement process is known to be fraught with several challenges, including its time and cost intensive nature; given the ex... read more
The convergence of cutting-edge innovation in information technology and biomedical science, with the increasing demand for remote solutions, has facilitated the emergence of advanced d... read more
Driven by the stringent regulatory guidelines issued to ensure safety of end-user and the growing pipeline of healthcare products, the demand for genotoxicity / ... read more
Growing interest for combination products, coupled with the ongoing challenges of combining drug / biologic with a medical device, is anticipated to drive the demand for outsour... read more
Rising complexities related to huge data volumes being generated in the healthcare sector, along with the need for visibility, control and synchronization in pr... read more
In order to overcome the limitations and challenges related to animal testing, researchers and industry stakeholders are gradually adopting organ-on-chip products and technologies, which offer mul... read more
In order to avail benefits, such as technical competence in sequencing large-sized genes, reduced cost, and fast delivery of high-quality data, researchers and industry players have demonstr... read more
Given the low toxicity, specific targeting and ability to offer higher biosafety, the bacteriophage therapeutics are actively being evaluated for the treatment of various infectious dise... read more
Given their low immunogenicity, diversified targets and ability to offer higher biosafety, the adeno-associated viral vectors are actively being evaluated for the development... read more
Currently approved antiviral drugs target only 10 of the 220 known viruses that are responsible for causing serious infection in humans, which has necessitated the development of ... read more
Over time, therapeutic vaccines have generated significant interest in the pharmaceutical industry owing to their safety, specificity, augmented immunity and long-term cli... read more
Post the global outbreak of the monkeypox disease in early 2022, there has been a surge in interest towards research for effective and safe vacci... read more
In order to avail benefits, such as technical competence, compliance with regulations, reduced production costs and on-time approval of biologics, innovators have shown prefe... read more
The present treatment landscape of chronic wound and bone healing is characterized by a variety of unmet needs; tissue engineering-based regeneration products have em... read more
Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various diseas... read more
In order to accommodate the growing demand for higher accuracy, greater resolution and improved sensitivity in analytical processes, various industry stakeholders are engaged in the developm... read more
In order to mitigate the complexities associated with achieving a long-acting profile, drug developers have been inclined towards the utilization of long-acting drug delivery... read more
Driven by the growing need to enhance palatability of oral drugs and drug adherence among pediatric and geriatric population, the demand for novel and advanced taste masking and taste assessment techn... read more
The recent surge in demand for vaccines amidst the COVID-19 pandemic has served to facilitate a strong case for organizations to opt for cell culture media for the development a... read more
The COVID-19 pandemic has led to an increase in the adoption of digital solutions, specifically among women, allowing remote monitoring of health and improvement in ov... read more
Upon realizing the numerous benefits offered by aptamers, industry stakeholders have undertaken several R&D initiatives focused on exploiting the use of aptamers for vari... read more
Driven by high success rates in clinical trials and the potential to confer sustained periods of disease remission, T-cell therapies have received significant financial support, with approved... read more
Given the need for accelerated bioprocessing operations, low-volume bioreactors have emerged as a relatively economic solution for parallelized cell cultivations an... read more
Owing to the recent approval of therapies, such as Elzonris®, Pluvicto®, there has been a substantial increase in the R&D activity to evaluate the use of ... read more
Driven by the growing awareness regarding the influence of diet on health and its potential to minimize diet-related disease risks, the nutrigenomics market is likely to w... read more
Rise in clinical research activity for genetically modified therapies has resulted in the increase in demand for vectors; offering lucrative opportunit... read more
Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical ex... read more
Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying... read more
Owing to their tumor-killing capability and therapeutic superiority to conventional therapies, TIL therapies are being actively evaluated to treat advance, incurable oncological disorders by various... read more
Blockchain has emerged as a viable solution for management / exchange of large volumes of healthcare data, demonstrating significant benefits in the healthcare ... read more
With growing applications of DNA in medical research, industry stakeholders are actively looking for technologies that not only facilitate parallelized synthesis of DNA ... read more
Over time, flow cytometry has gained considerable attention as an analytical method in disease diagnosis and drug development; however, it is associated with... read more
Given the potential of gene therapies to permanently cure a diverse array of clinical conditions at the genetic level, the current pipeline is r... read more
With the approval of HUMULIN®, the first genetically modified drug, scientific community has made significant progress in developing gene edited therapies based on programmable nucl... read more
Driven by the growing pipeline of lyophilized drugs, and increasing preference for self-medication, the demand for novel drug reconstitution systems is expected to rise in the coming years ... read more
In comparison to batch production methods, continuous manufacturing is not only cost and time-efficient, but also enables reduction in energy and manpower requ... read more
The success of currently employed artificial intelligence (AI) solutions has encouraged researchers to explore the potential of such technologies in the healthcare sector, with its prime fo... read more
Given the advanced features and cost saving potential, automatic sampling systems have been widely adopted by various stakeholders in biopharmaceutical industry, to monitor data in rea... read more
Given the high target specificity and favorable safety profiles offered by antibody based pharmacological interventions, the antibody discovery market has witn... read more
Upon realizing the numerous benefits offered by aptamers, industry stakeholders have undertaken several R&D initiatives focused on exploiting the use of aptamers for various pu... read more
Owing to the fact that a number of ADC developers are outsourcing various aspects of their business processes, CMOs engaged in this domain have undertaken several expansion initia... read more
In order to avail benefits, such as technical competence, reduced cost, and fast delivery of high-quality DNA and gene customized clones, several players have demonstrated a prefere... read more
Given the increased demand for biologics and various benefits of single-use technology, the biopharmaceutical manufacturers are gradually adopting single-use systems f... read more
Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufact... read more
Stakeholders in the pharmaceutical industry are currently exploring the implementation of artificial intelligence (AI) based tools to expedite drug discovery tim... read more
The success of currently approved RNAi drugs has encouraged researchers to explore the therapeutic potential of RNAi therapeutics and associated technologies, enabling their impl... read more
In recent years, the use of biosensors in drug discovery has been on the rise, driven by several technological advancements and the gr... read more
Given the various challenges associated with co-development of companion diagnostics and drug / therapy, drug developers prefer to rely on third-party service provi... read more
The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract service providers having continuous and semi-c... read more
The approval of three oral protein / peptide-based therapies has led to a substantial increase in the R&D initiatives being undertaken in this domain, to evaluate the use of s... read more
Characterized by a rapidly growing pipeline of biosimilars and novel biologics, and the existing challenges associated with lyophiliz... read more
Upon realizing the potential of this route of administration, industry stakeholders have initiated several R&D efforts focused on exploiting the use of intranasal therapeut... read more
In recent years, the potential of microbiome-based leads for the treatment of a myriad disease indications has been widely recognized, presenting lucra... read more
The crucial role of nanoparticles as drug delivery systems has been extensively studied; these molecules also played a key role in th... read more
The approval and success of Soliris® and other complement therapeutics has paved for the development of several drugs targetin... read more
Given the inherent expertise of CMOs and CDMOs, they are believed to be capable of enabling reduction in product development timelines, significant cost-benefits,... read more
In order to avail benefits, such as higher flexibility, reduced cost and assistance in meeting the rising demands, several pharmaceutical companies ha... read more
Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufactur... read more
In recent years, the potential of cell invasion and migration assays with respect to discovery, diagnosis and screening of diseases has been widely recognized, whic... read more
With the recent FDA approval of Tavenos™ for ANCA-associated vasculitis, myeloid cells have become an attractive target for pharmacological interventions, being deve... read more
Patient safety is one of the critical aspects of pharmaceutical industry, which makes it imperative for drug manufacturers and packaging service providers to evaluate the ... read more
With the approval of HUMULIN®, the first genetically modified drug, scientific community has made significant progress in developing gene edited therapies based on programmable nucl... read more
With six approved drugs, namely POLIVY™, LUMOXITI™, BESPONSA®, MYLOTARG™, KADCYLA®, ADCETRIS® and over 300 drugs underdevelopment, antibody drug con... read more
The demand for biopharmaceutical excipients has grown considerably in the past few years; they play a critical role in biologics development by... read more
Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis a... read more
Given the limitations of current clinical trial approaches, including inefficient patient management and data handling, trial sponsors are increasingly opting for innovative technologies and soft... read more
Driven by the development of novel platforms and advanced technologies, and the application of these molecules in research activities related to therapeutics and diag... read more
Clinical studies are presently known to capture 50% share of the overall exorbitant investments required for drug development; therefore, sponsors are actively assessing available ... read more
Given the growing healthcare burden related to chronic diseases, there is a need for safe devices that allow frequent or continuous medications; large volume injectors are des... read more
The growing demand for remote diagnosis and increased workload on radiologists has compelled hospitals / diagnostic centers to adopt teleradiology services, to not only expedite report turnar... read more
Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order... read more
Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth by altering chemical ... read more
Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presen... read more
Owing to the numerous benefits offered by biologics, this drug class has become an integral part of the overall pharmaceutical industry, having captured a significant market share over the past... read more
Given that conventional therapies have been unable to exhibit significant efficacy in the treatment of RAS mutated cancers, novel drugs, specifically targeting the RAS gene... read more
The delivery of drugs in ocular regions is known to be considerably more challenging; several pharmaceutical companies are actively undertaking initiatives to identify novel approa... read more
Amidst the COVID-19 pandemic, there has been an evident surge in the demand for high quality cell therapies intended for research and therapeutic purposes, presenting lucrat... read more
Given the inherent expertise of CMOs and CDMOs, they are believed to be capable of enabling reduction in product development timelines, significant cost-benefits, as... read more
Owing to their advanced features and cost saving potential, bioprocess controllers and automation systems have been adopted widely by stakeholders in order to optimize... read more
Driven by the growing pipeline of lyophilized drugs, and increasing preference for self-medication, the demand for novel drug reconstitution systems is expected to rise in the coming years ... read more
In the ongoing COVID-19 pandemic, a surge in the number of research studies has been observed, presenting lucrative opportunities for biospecimen service providers having the capabil... read more
Customized services, reduced cost and access to advanced technologies offered by contract research service providers, have promp... read more
With the emergence of blockbuster drugs, such as Gazyva® (for Chronic Lymphocytic Leukemia) and POTELEGIO® (for Sézary syndrome), Fc engineered an... read more
Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue s... read more
Considering the success of already approved drugs, such as Victoza® and Nplate®, and a healthy pipeline of promising candidates, the peptide therapeutics market is anticipated to... read more
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has pr... read more
With the growing pipeline of cell therapy products as potential treatments options for a myriad of diseases, drug developers are likely to collaborat... read more
Considering its potential to intricately alter genetic DNA, the CRISPR technology is being widely used to develop viable therapeutics for th... read more
Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of infla... read more
Given the various limitations of the conventional drug discovery methods, the innovator companies are increasingly adopting the advanced technologies, such ... read more
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and p... read more
Amidst the COVID-19 pandemic, there has been an evident surge in demand for standard quality antibodies for research, diagnosis and therapeutic ... read more
Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indicat... read more
Over past few years, pharmaceutical companies have outsourced various aspects of their R&D and clinical research processes to specialty contract research service providers, in order to rema... read more
Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one ... read more
Advances in molecular biology and tumor immunology have enabled the development of therapeutic fusion proteins, having the ability to activate immunologically cold microenvironments without t... read more
Amidst the COVID-19 pandemic, there has been an evident surge in demand for both vaccines and certain antibody therapeutics, which has presente... read more
Modular facilities offer the means for drug developers / manufacturers to ensure product quality, and flexibly use available infrastructure, thereby, en... read more
The growing complexities surrounding modern therapy development initiatives have caused biopharmaceutical companies to adopt available cloud-based solu... read more
The eLearning business is mostly driven by corporate training initiatives and distance education programs, leading to the development of cost friendly learning s... read more
The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies w... read more
Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this... read more
Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pe... read more
In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, t... read more
Driven by the urgent need to address off-target toxicity-related concerns and improve therapeutic outcomes of biologic drugs, several patient-centric medical device... read more
mRNA as a therapeutic / preventive agent has been demonstrated to be well tolerated in vivo, and can harness the cell’s translational machinery to invoke humoral an... read more
The anticipated growth in global diabetic patient population is likely to result in a significant rise in demand for novel, safe and more patient friendly drug ... read more
The anticipated growth in the global diabetic patient population is likely to translate into significant rise in demand for advanced, cost-effective and more patient friendly solutions for disease mo... read more
Besides portability, handheld X-ray scanners offer a wide range of benefits, including cost savings; in the initial days of the pandemic, such devices... read more
Driven by the potential treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene t... read more
Advances in 3D cell culturing, have led to the discovery of better scaffold fabrication techniques and also enabled various parts of the pro... read more
Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering dev... read more
STING pathway modulation, using appropriate pharmacological interventions, has emerged as a viable approach to harnessing ... read more
Growing awareness of the impending energy crisis and the need to reduce carbon emissions, have led to the development of AI-based ... read more
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to o... read more
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with th... read more
Till date, nearly 150 types of psychedelic therapeutics have been identified and there is a growing body of evidence supporting the ... read more
Given the success of approved repurposed therapeutics, such as Viagra® and Thalomid®, this approach has become a key lifecycle... read more
Over the years, various industry stakeholders have actively invested in the development and implementation of automation technologies for manufacturing operations, in order to min... read more
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable... read more
Rising demand for viral vectors coupled to lack of scalability and other concerns related to downstream purification, have led stakeholders in this domain to undertake vari... read more
With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand f... read more
Given the anticipated increase in demand for vaccines, stakeholders are actively focusing on the development and validation of novel delivery devices, in orde... read more
Reduced manufacturing costs, availability of cheap and skilled labor, coupled to a supportive regulatory landscape has compelle... read more
Proteome profiling is a technically complex and financially demanding field of research; as a result, both pharmaceutical companies and research institutes prefer... read more
Reduced manufacturing costs, availability of cheap and skilled labor and a supportive regulatory landscape in China has comp... read more
Given the success of approved peptide therapeutics, such as Victoza® and Nplate®,  the manufacturing demand has sub... read more
Owing to the numerous complexities associated with clinical research, medical device developers rely on contract service providers in order to reduce the risk... read more
The growing pipeline of therapeutics designed for subcutaneous delivery, coupled to the rising preference for self-medication, is expected to present lucr... read more
Empowered by technical developments in the field of biotechnology and the market opportunity associated with regenerative medicine, a number of research grou... read more
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the bene... read more
Given the evident immunogenicity, cytotoxicity and high production cost based concerns associated with viral vectors, companies are compelled to... read more
With over 1,000 highly potent drugs in the development pipeline, the demand for developing and manufacturing of such products is an... read more
Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the frag... read more
Compared to batch production methods, continuous manufacturing is not only more time-efficient, but is also associated with reduced energy nee... read more
Increasing awareness related to the importance of reducing carbon footprint across the globe, has compelled individuals to adopt ... read more
The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting u... read more
The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune che... read more
The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological resear... read more
Driven by the growing pipeline of injectable drugs, and increasing preference for self-medication, the demand for fill/finish s... read more
Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed ... read more
Outsourcing is presently considered the preferred business model for the development of companion diagnostic tests for personalized therapeu... read more
In order to reduce risk of device recalls and expedite time to market, medical device developers rely on contract servi... read more
The success of approved stem cell therapies has caused a surge in interest of biopharma developers in this field; many innovator companies are currently pr... read more
With multi-billion funding initiatives publicly disclosed by various government agencies, and private investors, various leadin... read more
The genome sequencing domain has witnessed a surge in the availability of service providers, With gene sequencing costs having come down by several ord... read more
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such pr... read more
The current rate of data generation, coupled to the growing concerns regarding its safety, are anticipated to propel the growth of the colocation da... read more
Increasing demand for energy efficient lighting solutions and growing number of smart city projects across the globe are amongst the key drivers behind th... read more
Rise in prevalence of chronic diseases and the corresponding need to medicate frequently, have led to an increase in demand for safe, self-administrable dosing options. Autoinjectors are conside... read more
Using DNA to develop encoded libraries of pharmacological leads has enabled medical research community to assemble and maintain large ... read more
Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device, and a product life cycle management tool. Consequently, they have become indisp... read more
The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell ther... read more
The growing global urgency to reduce carbon footprint, coupled to the long life and low maintenance requirements of lithium ion batteries,... read more
Over time, biopharmaceutical companies have realized the importance of integrating advanced software into the cell and advanced therapies supply chai... read more
Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic product... read more
Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics ... read more
Over the years, there has been a rise in preference for self-administration of drugs / therapies, resulting in an increasing deman... read more
The recent surge in interest in genetically-modified therapies has resulted in a steep rise in demand for different vectors for fundamental and pharmacological resear... read more
Driven by a robust and growing pipeline of stem cell therapies, the demand for development and manufacturing services for such advanced product candidates is antici... read more
The growing popularity and therapeutic potential of antibody drug conjugates (ADCs) is evident in the rapid growth in intellectual capital, financing... read more
The shift to self-administration of medication, coupled to the need to improve therapy adherence, have driven device developers to design versatile drug delivery devices capable of minimizing ... read more
The success of the approved gene therapies has led to an upward surge in the interest of biopharmaceutical developers in this field, resulting in a significant... read more
Given the recent success of KYMRIAH® and YESCARTA®, the current focus is on establishing a sustainable chimeric antigen receptor T (CAR-T) cell therapy mark... read more
Given the rise in clinical R&D activity focused on gene therapies and other advanced therapy medicinal products, there has been a surge in deman... read more
Owing to the benefits offered in terms of streamlining pharmaceutical filling operations and cutting down on associated costs, pre-sterilized ... read more
Owing to numerous technical and regulatory challenges related to the development and production of medical devices, outsourcing has become a po... read more
Having demonstrated the ability to offer improved treatment related outcomes and also enhance the quality of lives of patients suffering from ... read more
Advances in biotechnology and genome analysis have enabled the identification of several novel cancer biomarkers, which are presently being used for a variety o... read more
The steadily growing demand for vaccines, coupled to the discovery and development of a variety of both preventive and therapeutic vaccine products, has generated a ... read more
Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that... read more
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have turned to more versatile materials for the fabrication of co... read more
Having demonstrated the ability to selectively eradicate tumor cells from the body with minimal treatment-related side effects, T-cell therapies have emerg... read more
Advances in biotechnology and genome analysis have enabled the identification of several novel cancer biomarkers, which are pre... read more
Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveill... read more
Roots Analysis has announced the addition of “Companion Diagnostics Market (2nd Edition), 2019-2030” report to it... read more
Roots Analysis has announced the addition of “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030” rep... read more
Roots Analysis has announced the addition of “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030” report to its list of offerings.&nbs... read more
Roots Analysis has announced the addition of “Extractables and Leachables Testing Services Market, 2018-2028” report to it... read more
Roots Analysis has announced the addition of “Medical Device CROs Market, 2018-2030” report to its list of offerings. Shifali Gupta, the principal analyst, stated, “Give... read more
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (2nd Edition), 2018-2030” report to its list of offerings. Natasha Thakur, the principal analyst, stated, &ldq... read more
Roots Analysis has announced the addition of “Blockchain in Genomic Data Management: Market Landscape and Competitive Insights, 2018-2030” report to its list o... read more
Roots Analysis has announced the addition of “Real World Evidence: Market Landscape and Competitive Insights, 2018-2030” report to its list ... read more
Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028” report to i... read more
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (2nd Edition), 2018-2030” report to its list of offerings. Natasha Thakur, the principal ana... read more
Roots Analysis has announced the addition of “Computer-Aided Drug Discovery Services Market, 2018-2030” report to its list of offerings. Akash Mishra, the principal analy... read more
Roots Analysis has announced the addition of “Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 20... read more
Roots Analysis has announced the release of its “T-Cell Immunotherapy Market (3rd Edition), 2018-2030”report. Pemba Lahmo, the principal analyst, stated, “With two approved th... read more
Roots Analysis has announced the addition of “Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030” report to its list of offerings... read more
Roots Analysis announced the addition of “Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030” report to its list of offerings. Roh... read more
Roots Analysis has announced the addition of 3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035’ report to its list of offerings. The report provides a comprehensive analysis of the current landsc... read more
Roots Analysis has announced the addition of ‘Antibody Drug Conjugates Market (4th Edition), 2017-2030’ report to their list of offerings. The report features an extensive study on current landscape and the future out... read more
Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical / Biotechnology Industry, 2017-2030”report to their list of offerings. The report features an extensive study on current landscape ... read more
Roots Analysis has announced the addition of “Cell Line Development Services Market, 2017-2027” report to its list of offerings. The report features an extensive study on the rapidly growing market of c... read more
Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms, 2017-2027” report to its list of offerings. The report features an extensive study on the current market l... read more
Roots Analysis has announced the addition of the “Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape of therapies for the treat... read more
Roots Analysis has announced the addition of “Global Non-Invasive Prenatal Testing and Newborn Screening Market, 2017-2030” report to its list of offerings. The report p... read more
Roots Analysis has announced the addition of “Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017 - 2027” report to its list of offerings. The report provides an extensive study of the contract man... read more
Roots Analysis has announced the addition of “Non-Invasive Cancer Diagnostics Market (2nd Edition), 2017-2030” report to its list of offerings. The report provides a comprehensive analysis of the current landscape and future outl... read more
Roots Analysis has announced the addition of “Deep Learning in Drug Discovery and Diagnostics, 2017-2035” report to its list of offerings. The report provides a comprehens... read more
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market, 2017-2027” report to its list of offerings. The report provides an extensive study on the current landscape of the rapidly growing mark... read more
Roots Analysis has announced the addition of “Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026” report to its portfolio. The report provides a... read more
Roots Analysis has announced the addition of the “T-Cell Immunotherapy Market, 2017-2030 (2nd edition)” report to its portfolio. The report features an extensive study of the current market lands... read more
Roots Analysis has announced the addition of the “Prefilled Syringes Market (4th Edition), 2017-2026” report to its list of offerings. The report provides a comprehensive analysis of the current state and ... read more
Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapi... read more
Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players a... read more
Roots Analysis has announced the addition of the “HDAC Inhibitors Market, 2016-2026” report to their list of offerings. It provides a comprehensive study on the current landscape of the evolving pipeline in ... read more
Roots Analysis has announced the addition of the “Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026” report to its list of offerings. The report provides a deta... read more
Roots Analysis has announced the addition of “Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026” report to its portfolio. The report provides a comprehensive analys... read more
Roots Analysis has announced the addition of the “Vaccine Contract Manufacturing Market, 2016-2026” report to its list of offerings. The report provides an extensive study of the current market lan... read more
Roots Analysis has announced the addition of “Global Autoinjectors Market, 2016-2026” report to its portfolio. The report provides a comprehensive analysis of the current state of autoinjectors market and the lik... read more
Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition)  report to its portfolio. The report provides an extensive study of the contract ... read more
Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/s... read more
Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook... read more
Roots Analysis has announced the addition of “Microbiome Therapeutics Market, 2015-2030” report to their offering. The report provides a comprehensive study on the current landscape and the future outlook of the evolving pipe... read more
Roots Analysis has announced the addition of “RNAi Therapeutics Market, 2015-2030” report to their offering. The study offers a comprehensive analysis of the current landscape and future outlook of t... read more
Roots Analysis has announced the addition of “Non-invasive Cancer Diagnostics Market, 2015-2030” report to their offering. The report offers an extensive study of several commercialized and / or under development non-invasive diag... read more
After the early success of Immune Checkpoint Inhibitors, T-cell immunotherapy has emerged as another innovative and potent arm of the immuno-oncology market. Characterised by key features such as target specifi... read more
Roots Analysis has announced the addition of “NASH Drugs Market, 2015-2025” report to their offering. The study offers a comprehensive analysis of the current landscape and future outlook of the evolving pipeline ... read more
Roots Analysis has announced the addition of “Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025” report to its portfolio. The study provides a comprehensive analysis of the current market landscape and fu... read more
Roots Analysis has announced the addition of “3D Culture Market, 2015-2025” report to their offering. The 3D culture approach is emerging as a promising tool that surmounts the limitations posed by monolayer or 2D culture syste... read more
Roots Analysis has announced the addition of “Sustained Release Ocular Drug Delivery Systems Market, 2015-2025 (2nd edition)” report to their offering. The report provides an extensive study of the emerging marke... read more
Roots Analysis has announced the addition of “BBB Technologies: Novel CNS Drug Delivery Approaches, 2015 - 2030” report to its portfolio.  The report provides an extensive study of the emerging market of BBB... read more
Roots Analysis has announced the addition of ‘Biopharmaceutical Contract Manufacturing Market, 2015-2025’ report to their offering. The report provides an extensive study of the contract manufacturing opportunity for this ... read more
Roots Analysis has announced the addition of “Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025” report to their offering. The report provides a comprehensive analysis of the current mark... read more
Roots Analysis has announced the addition of “Gene Therapy Market, 2015-2025” report to their offering. The market currently has only five approved therapies; of these, four are commercialised in geogr... read more
Roots Analysis has announced the addition of “Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas” report to its portfolio. The report provides a comprehensive study of the pipeline drugs being developed fo... read more
Roots Analysis has announced the addition of “Immune Checkpoint Inhibitors Market, 2014-2024” report to their offering. The study offers a comprehensive view of the emerging market of CTLA-4... read more
Roots Analysis has announced the addition of “Needlestick Safety Injection Devices, 2014 - 2024” report to their offering. The study offers a comprehensive view of the product portfolio of safety injection devices, their compara... read more
Roots Analysis has announced the addition of “Large Volume Wearable Injectors, 2014-2025” report to its portfolio. The report is the second edition of the original publication titled “Bolus Injectors, 2014-2024” re... read more
Roots Analysis has announced the addition of “Glycated Haemoglobin (HbA1c) Testing Market, 2014 - 2024” report to its portfolio.  The report provides an extensive study of the growing market for HbA1c t... read more
Roots Analysis has announced the addition of “HPAPIs and Cytotoxic Drugs Manufacturing Market” report to their portfolio. The report provides an extensive study of the contract manufacturing ... read more
Roots Analysis has just released the 2nd edition of its publication "Prefilled Syringes Market, 2014 - 2024 (2nd edition)", acomprehensive study on the product pipeline, technological progr... read more
Roots Analysis has announced the addition of “Companion Diagnostics Market, 2014 - 2024 (2nd edition)” report to their offering. The study offers an extensive analysis of this growing marke... read more
Roots Analysis has announced the addition of “Sustained Release Ocular Drug Delivery Systems Market, 2014-2024” report to their offering. The report provides an extensive study of this field, focusing on commerc... read more
Roots Analysis has announced the addition of the “Single-use Bioreactors, 2014-2024” report to their offering. The report provides an extensive study of this emerging field, including detailed sales forecast of single-use bioreactors in the... read more
Roots Analysis has announced addition of the “Antibody Drug Conjugates: Contract Manufacturing Market, 2014-2024” report to their offering. The report provides an extensive stud... read more
A new report published by Roots Analysis provides a comprehensive view of the emerging market of “Oral Proteins and Peptides”. Apart from profiling the various drugs which are in different stages of clinical trials, the study also talks about many... read more
Roots Analysis latest publication on “Bolus Injectors” predicts that the market for these devices is likely to be ~USD 8.8 billion by 2024. Also known as ‘patch pumps’ and ‘large volume injectors’, the first c... read more
Roots Analysis has announced addition of the “Bispecific Antibody Therapeutics Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including... read more
Roots Analysis has announced addition of the “Fc Protein and Glycoengineered Antibodies Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including detailed s... read more
A new report published by Roots Analysis Private Limited estimates the market for Antibody Drug Conjugates (ADCs) to grow to USD 9 billion annually by 2023. The report provides an extensive study of this em... read more
A new report published by Roots Analysis Private Ltd. forecasts the market for prefilled syringe systems to grow at a CAGR of 13.8% during the forecast period 2012-2018. According to the report titled ‘Prefilled Syringes Wor... read more
A new report published by Roots Analysis Private Ltd., a research group focused solely in the pharmaceutical industry, estimates that Companion Diagnostics market was worth USD 193 MM in 2012. This represented 10.1% of the total Personali... read more
A new report released by Roots Analysis Private Ltd. forecasts the market for Alzheimer’s drugs to grow at a CAGR of 8.0% during the period 2012-2017. According to the report titled ‘Alzheimer’s Drugs Market, 2012-2017... read more

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry